Amesite’s NurseMagic™ Emerges as Top Contender in AI Nursing Tools
Event summary
- Amesite’s NurseMagic™ named finalist for Nurse.org ‘Best of Nursing: AI Nursing Tool’ Award, less than two years post-launch.
- Platform targets $460–510 billion U.S. post-acute care market (2025), projected to reach $800 billion by 2035.
- Revenue growth accelerated with enterprise adoption: 82% QoQ after July 2025 launch of census-based Enterprise tier, followed by 69% QoQ increase.
- AI-native EMR announced in December 2025 aims to replace legacy systems in long-term care and post-acute segments.
The big picture
Amesite’s recognition by Nurse.org underscores the growing demand for AI-driven solutions in post-acute care, where administrative burdens divert clinicians from patient care. The company’s user-first scaling strategy—validating NurseMagic™ with individual nurses before enterprise rollout—positions it to capture share in a market poised for explosive growth. The shift toward an AI-native EMR could further solidify its competitive edge, but execution risks remain as it navigates regulatory and operational hurdles.
What we're watching
- Market Expansion
- Whether Amesite can sustain its rapid revenue growth as it scales NurseMagic™ across the fragmented post-acute care market.
- Competitive Positioning
- How NurseMagic™’s AI-native EMR will differentiate against legacy systems in a segment forecasted for double-digit annual growth through 2035.
- Regulatory Compliance
- The pace at which Amesite integrates governance and defensibility features to meet evolving healthcare regulations.
Our editorial coverage:
Related topics